Paperpal Prime Logo

Cell Reports Medicine : Impact Factor & More

eISSN: 2666-3791pISSN: 2666-3791
JournalOpen Access

Key Metrics

CiteScore
7.1
Impact Factor
10 - 15
Scite Index
0.90 5-Year SI
SJR
Q3Biochemistry, Genetics and Molecular Biology (all)
SNIP
2.45
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cell Reports Medicine

Cell Reports Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Monthly
Article Processing ChargesUSD 5460
Publication Time17
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2020
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Cell Reports Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cell Reports Medicine

Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma.
  • 7 Aug 2026
  • Cell reports. Medicine
Multi-modal AI-enabled steatotic liver disease diagnostics using facial images and metabolomics.
  • 7 Aug 2026
  • Cell reports. Medicine
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
  • 6 Aug 2026
  • Cell reports. Medicine
Biomarker-guided responses in patient-derived organoids predict effective therapies in breast cancer.
  • 6 Aug 2026
  • Cell reports. Medicine
Microenvironment-responsive magnesium stents for targeted atherosclerotic plaque removal and restenosis mitigation.
  • 6 Aug 2026
  • Cell reports. Medicine
Glutamine-restricted diets restore sensitivity to KRASG12D inhibitor through the reversal of ANXA1 mediated metabolic reprogramming.
  • 6 Aug 2026
  • Cell reports. Medicine
Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma.
  • 7 Aug 2026
  • Cell reports. Medicine
Multi-modal AI-enabled steatotic liver disease diagnostics using facial images and metabolomics.
  • 7 Aug 2026
  • Cell reports. Medicine
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
  • 6 Aug 2026
  • Cell reports. Medicine
Biomarker-guided responses in patient-derived organoids predict effective therapies in breast cancer.
  • 6 Aug 2026
  • Cell reports. Medicine
Microenvironment-responsive magnesium stents for targeted atherosclerotic plaque removal and restenosis mitigation.
  • 6 Aug 2026
  • Cell reports. Medicine
Glutamine-restricted diets restore sensitivity to KRASG12D inhibitor through the reversal of ANXA1 mediated metabolic reprogramming.
  • 6 Aug 2026
  • Cell reports. Medicine

FAQs on Cell Reports Medicine